Article
METTL13 Inhibits Progression of Clear Cell Renal Cell Carcinoma with Repression on PI3K/AKT/mTOR/HIF-1α Pathway and c-Myc Expression
2021-02-19
Abstract excerpt
<title>Abstract</title> <p>Background: Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive type of renal malignancy. Methyltransferase like 13 (METTL13) functions as an oncogene in most of human cancers, but its function and mechanism in ccRCC remain unreported. <h4>Methods:</h4> qRT-PCR, western blot and immunohistochemistry were used to detect METTL13’s expressions in tissues. The effects...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7fa4609a-cf47-503f-ab83-f7ae01abb906
- DOI
- 10.21203/rs.3.rs-214061/v1
